CTLA4 and acute lymphoblastic leukemia: For patients with ALL, the C allele of rs11571315 (CC vs. CT+TT, p = 0.0289, OR = 6.14, 95% CI = 1.21–30.99) in the promoter region of CTLA4 was found to associate with higher risk for mortality.